Bionano Genomics, Inc. (NASDAQ:BNGO – Get Free Report)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $5.82, but opened at $5.70. Bionano Genomics shares last traded at $5.42, with a volume of 63,738 shares trading hands.
Wall Street Analyst Weigh In
Separately, LADENBURG THALM/SH SH lowered Bionano Genomics from a “buy” rating to a “neutral” rating in a research note on Friday, November 15th.
Check Out Our Latest Stock Report on BNGO
Bionano Genomics Stock Performance
Institutional Investors Weigh In On Bionano Genomics
A number of institutional investors have recently added to or reduced their stakes in BNGO. Carret Asset Management LLC boosted its position in Bionano Genomics by 89.0% during the third quarter. Carret Asset Management LLC now owns 85,055 shares of the company’s stock valued at $39,000 after purchasing an additional 40,055 shares in the last quarter. GSA Capital Partners LLP purchased a new stake in shares of Bionano Genomics during the third quarter worth about $46,000. Finally, Geode Capital Management LLC grew its stake in shares of Bionano Genomics by 47.3% during the third quarter. Geode Capital Management LLC now owns 882,854 shares of the company’s stock worth $401,000 after acquiring an additional 283,639 shares during the last quarter. Institutional investors own 11.35% of the company’s stock.
Bionano Genomics Company Profile
Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.
Recommended Stories
- Five stocks we like better than Bionano Genomics
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- What Does the Future Hold for Eli Lilly?
- How to Plot Fibonacci Price Inflection Levels
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
- What is the FTSE 100 index?
- 3 Consumer Stocks Call Option Traders Are Betting Big On
Receive News & Ratings for Bionano Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionano Genomics and related companies with MarketBeat.com's FREE daily email newsletter.